CAS: 56519-71-2; Propane-1,3-Diyl Dioctanoate

结构式图片

相似化合物

109-43-3 105-99-7 123-79-5

合成工艺路线路线简述

    📜辛酸,1,3-丙二醇 反应生成 丙二醇二辛酸酯
    参考文献:Breusch; Oguzer,Chemische Berichte,1955,Vol. 88,P. 1511,1516,1518
    标题:Breusch; Oguzer,Chemische Berichte,1955,Vol. 88,P. 1511,1516,1518

    海关参考信息

    专利信息


    专利号:US-2018312534-A1
    优先权日:2015-10-16
    标题:Fluorescent anticancer platinum drugs
    发明人:SARKAR ARINDAM; MANDAL SWADHIN KUMAR; SENGUPTA ANIRUDDHA; BISWAS GOUTAM; DUTTA PRADIP; SHARMA RUPALI; RAJ JUSTIN PAUL; SURYAVANSHI HEMANT; KUMARI SMITA
    权利人:INVICTUS ONCOLOGY PVT LTD
    摘要:The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to fluorescent platinum based compounds. The disclosure further relates to synthesis of said fluorescent platinum based compounds, nanoparticles and compositions comprising said fluorescent platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by the fluorescence changes between aforesaid platinum based compounds and corresponding free ligands, nanoparticles and compositions.

    专利号:US-10730899-B2
    优先权日:2013-06-14
    标 题 :Lipid-based platinum compounds and nanoparticles
    发明人:SENGUPTA SHILADITYA; ROY MONIDEEPA; SARKAR ARINDAM; HOSSAIN SK SAMAD; SENGUPTA ANIRUDDHA; DUTTA PRADIP; ANSARI AASIF
    权利人:AKAMARA THERAPEUTICS INC
    摘要:The present disclosure is in relation to the field of nanotechnology and cancer therapeutics. In particular, the present disclosure relates to platinum based compounds comprising platinum moiety, linker moiety and lipid moiety and corresponding nanoparticles thereof. The disclosure further relates to synthesis of said platinum based compounds, nanoparticles and compositions comprising said platinum based compounds/nanoparticles. The disclosure also relates to methods of managing cancer by employing aforesaid carbene compounds, platinum based compounds, nanoparticles and compositions thereof.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Final Report 9/2017 Available from CIR
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知